Open AccessPrevalence and Multidrug Resistance Pattern of E. Coli among Urinary Tract Infection Patients in Tertiary Care Hospital of Multan
Author(s) -
Hubza Ruatt Khan,
Mehvish Javeed,
Asghar Javed,
Nisma Farooq
Publication year - 2021
Publication title -
journal of bioresource management
Language(s) - English
Resource type - Journals
ISSN - 2309-3854
DOI - 10.35691/jbm.1202.0207
Subject(s) - nitrofurantoin , ciprofloxacin , medicine , ampicillin , antibiotic resistance , fosfomycin , antimicrobial , gentamicin , microbiology and biotechnology , bacteremia , drug resistance , multiple drug resistance , amoxicillin , antibiotics , biology
Urinary Tract Infection is alarming problem worldwide due to the intensity of antimicrobial resistance. Escherichia coli is the most predominant organism in UTI. This study was planned to evaluate demographic parameters, the prevalence of E. coli, and antimicrobial resistance patterns among E. coli isolates from UTI patients in Nishtar Hospital of Multan from January to June 2018. A total of 350 mid-stream urine samples were collected from different patients having age group from 25 to 60 years and processed by standard laboratory procedures. Out of 350 samples, 100 samples were observed as critical bacteremia. Escherichia coli and Klebsiella pneumonia were the most persistent (47 % and 19 % individually) among the Gram-negative pathogens followed by S. aureus (14 %), Enterobacter spp. (11 %) and Candida (9 %) respectively. The incidence of UTI was found higher in 25-35 age groups. The prevalence of UTI with E. coli as an infectious agent was 72 % in females, and 28 % in males. The prevalence of E. coli was more in rural areas (70 %) than in urban areas (26 %). The antimicrobial testing against E. coli showed the highest resistance to amoxicillin (65.9 %) and ciprofloxacin (38.2 %), whereas highly sensitive rate observed against Fosfomycin (FOS) (95.7 %), Gentamicin (GEN) (89.3 %), and Nitrofurantoin (NIT) (85 %) respectively. The increased resistance against ampicillin and ciprofloxacin was observed in Multan have a great emerging problem so there is a need for effective prevention strategies for the E. coli drug resistance and successful surveillance required to be improved.